Dishman Carbogen Amcis Ltd
Pharmaceuticals & Biotechnology | Small Cap
Health Score : 5.38Dishman Carbogen Amcis Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strong solvency and growth, indicating a solid foundation and expansion in key areas. However, liquidity and efficiency are areas of concern, suggesting challenges in managing short-term obligations and asset utilization. Profitability metrics are also varied, with some positive gross and operating margins offset by negative returns on equity and net margins. The company's coverage ratios are weak, indicating potential difficulties in meeting its interest obligations. Overall, while the company exhibits growth potential and financial stability, it needs to address its liquidity and efficiency challenges to ensure sustained financial health. It's important to consider the unique dynamics of the Healthcare Services industry, which can significantly impact financial ratios.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio10.00
- Financial Ratio3.20
- Profitability Ratio6.60
- Efficiency Ratio2.67
- Coverage Ratio2.00
- Solvency Ratio10.00
- Liquidity Ratio3.50
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentWeak
- 1 HourBullish
- 2 HoursNeutral
- 4 HoursNeutral
- 1 DayBearish
- 1 WeekNeutral
- 1 MonthNeutral
Health Score : 5.38Dishman Carbogen Amcis Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strong solvency and growth, indicating a solid foundation and expansion in key areas. However, liquidity and efficiency are areas of concern, suggesting challenges in managing short-term obligations and asset utilization. Profitability metrics are also varied, with some positive gross and operating margins offset by negative returns on equity and net margins. The company's coverage ratios are weak, indicating potential difficulties in meeting its interest obligations. Overall, while the company exhibits growth potential and financial stability, it needs to address its liquidity and efficiency challenges to ensure sustained financial health. It's important to consider the unique dynamics of the Healthcare Services industry, which can significantly impact financial ratios.
Overall Valuation Score
P/E RATIO (TTM)
-69.68
Industry Median
28.62
Small Cap Median
27.17
P/E RATIO
27.45
P/B RATIO
0.40
Industry Median
3.17
Small Cap Median
2.62
P/S RATIO
0.91
Industry Median
3.42
Small Cap Median
2.55
Others
PEG RATIO
0.00
EV/EBITDA RATIO
5.69
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹170.72 as on Jun 20, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
Growth Score : 10.00The growth ratios paint a promising picture of the company's expansion. The company has a strong growth position. This growth momentum positions the company favorably for future success. On the other hand, the company needs to sustain its growth position.
Revenue Growth RateExcellentOperating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthExcellentAsset Growth RateExcellentNet Income Growth RateExcellent| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 11.98 | 12.7 | 8.41 | 3.67 | 8.11 |
| Operating Profit Growth Rate | 20.8 | 0.3 | -13.86 | 63.99 | 20.68 |
| Earnings Per Share (EPS) Growth | -110.92 | -265.22 | 415.26 | -102.15 | 2861.9 |
| Asset Growth Rate | 3.33 | 9.32 | 1.4 | 4.35 | 19.39 |
| Net Income Growth Rate | -110.91 | -266.67 | 410 | -101.96 | 3133.33 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Financial Score : 3.20The financial ratios present a mixed picture of the company's financial performance. The company has a mixed financial position. The company's financial ratios can provide valuable insights into its overall financial health and performance. On the other hand, the company needs to improve its financial position.
Adjusted Earnings Per Share (Adjusted EPS)Poor
Cash Earnings Per Share (Cash EPS)WeakBook Value Per ShareExcellentDividend Per Share (DPS)PoorCapital Expenditures (CapEx)Poor| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 3.23 | -0.58 | -9.74 | -1.23 | 6.39 |
| Cash Earnings Per Share (Cash EPS) | 21.03 | 16.19 | 10.19 | 19.16 | 28.13 |
| Book Value Per Share | 358 | 374.77 | 363.03 | 376.19 | 430.77 |
| Dividend Per Share (DPS) | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures (CapEx) | 456 | 619 | 303 | 216 | 267 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
Profitability Score : 6.60The profitability ratios present a mixed picture of the company's profitability. While the gross and operating margins are positive, the returns on equity and net margins are negative. The company has a mixed profitability position. Improving profitability will be crucial for future success. The company's profitability ratios can provide valuable insights into its overall financial health and performance. On the other hand, the company needs to improve its profitability position.
Gross Profit MarginExcellentReturn on Capital Employed (ROCE)ExcellentReturn on Equity (ROE)PoorReturn on Assets (ROA)WeakOperating MarginExcellentNet MarginPoor| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 1.07 | 2.11 | -0.96 | 6.45 | 7.74 |
| Return on Capital Employed (ROCE) | 1 | 1 | 0 | 2 | 3 |
| Return on Equity (ROE) | 0.32 | -0.52 | -2.72 | 0.05 | 1.45 |
| Return on Assets (ROA) | 3.83 | 3.52 | 2.99 | 4.7 | 4.75 |
| Operating Margin | 15.46 | 13.76 | 10.93 | 17.29 | 19.3 |
| Net Margin | 0.84 | -1.24 | -5.85 | 0.11 | 3.31 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
Efficiency Score : 2.67The company faces challenges in asset utilization. The turnover ratios are low, indicating that the company is not efficiently generating revenue from its assets. The company has a low efficiency position. Improving asset turnover can lead to increased profitability and better utilization of resources. On the other hand, the company needs to improve its efficiency position.
Fixed Asset Turnover RatioPoorInventory Turnover RatioWeakReceivables Turnover RatioWeakDays Sales in Inventory RatioPoorReceivable DaysPoorCapital Turnover RatioPoor| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 0.37 | 0.39 | 0.39 | 0.38 | 0.35 |
| Inventory Turnover Ratio | 3.65 | 3.26 | 3.13 | 2.85 | 2.82 |
| Receivables Turnover Ratio | 4.79 | 4.54 | 4.87 | 4.72 | 4.38 |
| Days Sales in Inventory Ratio | 100 | 111.96 | 116.61 | 128.07 | 129.43 |
| Receivable Days | 76.2 | 80.4 | 74.95 | 77.33 | 83.33 |
| Capital Turnover Ratio | 0.32 | 0.33 | 0.42 | 0.37 | 0.34 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
Coverage Score : 2.00The coverage ratios raise concerns about the company's ability to meet its debt obligations. The company has a low coverage position. This situation warrants careful monitoring to ensure the company can meet its financial commitments. The company's low coverage ratios can make it difficult to attract investors and lenders, potentially limiting access to capital for growth and expansion. On the other hand, the company needs to improve its coverage position.
Interest Coverage RatioPoorEquity Dividend Coverage RatioPoor| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 0.93 | 0.36 | -0.02 | 1.12 | 1.6 |
| Equity Dividend Coverage Ratio |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
Solvency Score : 10.00The solvency ratios provide a positive outlook on the company's long-term financial stability. The company has a strong solvency position. These ratios indicate that the company is well-positioned to manage its debt obligations. The company's strong solvency ratios can attract investors and lenders, providing access to capital for growth and expansion. On the other hand, the company needs to maintain its solvency position.
Debt RatioExcellentDebt to Equity RatioExcellentEquity RatioExcellentDebt To Asset RatioExcellent| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.17 | 0.2 | 0.1 | 0.2 | 0.22 |
| Debt to Equity Ratio | 0.2 | 0.25 | 0.11 | 0.25 | 0.28 |
| Equity Ratio | 0.83 | 0.8 | 0.9 | 0.8 | 0.78 |
| Debt To Asset Ratio | 0.14 | 0.15 | 0.06 | 0.15 | 0.15 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
Liquidity Score : 3.50The liquidity position reveals challenges in meeting short-term obligations. While maintaining some cash reserves, the ratios suggest potential difficulties in converting assets into cash quickly. The company might face issues in managing its current liabilities. This situation warrants careful monitoring to ensure the company can meet its immediate financial commitments and maintain smooth operations. On the other hand, the company has some strengths such as operating cash flow.
Current RatioPoorQuick RatioWeakCash RatioWeakOperating Cash Flow RatioWeak| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 0.92 | 0.89 | 0.63 | 0.88 | 0.93 |
| Quick Ratio | 0.58 | 0.53 | 0.36 | 0.54 | 0.64 |
| Cash Ratio | 0.09 | 0.09 | 0.12 | 0.19 | 0.29 |
| Operating Cash Flow Ratio | 0.19 | 0.12 | 0.11 | 0.14 | 0.14 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Amrutanjan Health Care Ltd | 8.25 | 77.37 | Highly Overvalued | 31.00 | 20.03 | 21.00 |
| 2 | Windlas Biotech Ltd | 7.52 | 25.92 | Neutral | 105.00 | 32.19 | 66.00 |
| 3 | Innova Captab Ltd | 7.36 | 38.55 | Overvalued | 243.00 | 14.63 | 141.00 |
| 4 | Hikal Ltd | 7.13 | -51.71 | Neutral | 220.00 | -3.95 | -49.00 |
| 5 | RPG Life Sciences Ltd | 7.12 | 32.70 | Neutral | 147.00 | 69.64 | 115.00 |
| 6 | Morepen Laboratories Ltd | 7.12 | 28.61 | Neutral | 126.00 | 1.21 | 96.00 |
| 7 | Alembic Ltd | 7.06 | 7.28 | Undervalued | 90.00 | 4.85 | 317.00 |
| 8 | SMS Pharmaceuticals Ltd | 5.94 | 34.77 | Neutral | 171.00 | 9.35 | 102.00 |
| 9 | Gufic BioSciences Ltd | 5.49 | 55.51 | Neutral | 151.00 | 6.30 | 64.00 |
| 10 | Dishman Carbogen Amcis Ltd | 5.38 | 27.45 | Neutral | 566.00 | -2.45 | 97.00 |
| 11 | IOL Chemicals & Pharmaceuticals Ltd | 5.31 | 27.76 | Undervalued | 269.00 | 4.69 | 138.00 |
| 12 | Indoco Remedies Ltd | 5.26 | -22.79 | Neutral | 142.00 | -0.61 | -99.00 |
| 13 | Aarti Drugs Ltd | 5.07 | 17.34 | Undervalued | 309.00 | 18.54 | 195.00 |
| 14 | Orchid Pharma Ltd | 4.85 | 241.74 | Neutral | 41.00 | 8.91 | 21.00 |
| 15 | Sequent Scientific Ltd | 4.61 | 293.05 | Overvalued | 162.00 | 0.63 | 32.00 |
| 16 | Sun Pharma Advanced Research Company Ltd | 4.35 | 4.97 | Neutral | 1599.00 | 47.83 | 1553.00 |
| 17 | Solara Active Pharma Sciences Ltd | 4.34 | -274.68 | Neutral | 187.00 | -1.50 | -7.00 |
| 18 | Zota Health Care Ltd | 3.97 | -61.25 | Neutral | 19.00 | 8.06 | -74.00 |
Balanced ManagementThe management effectiveness of Dishman Carbogen Amcis Ltd is mixed. While revenue has grown, profitability metrics like ROCE remain weak. Increased borrowings and interest expenses raise concerns about financial leverage. Promoter holding remains consistent, but declining DII holding could be a concern.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Promoter Holding | 59.32% | Consistent promoter commitment |
| Revenue Growth | Positive | Indicates market traction | |
| CONS | ROCE | 0% (Mar 2024) | Inefficient capital allocation |
| DII Holding | Declining | Reduced institutional confidence |
Financial Performance & GrowthAverageCapital Efficiency & ReturnsPoorFinancial Health & PrudenceWeakShareholding & Ownership StructureAverageFinancial Performance & Growth
Dishman Carbogen Amcis Ltd. shows inconsistent financial performance. While sales have grown, profit growth has been volatile. YOY Sales Growth % has fluctuated significantly, with a notable drop in June 2024. The operating profit margin has improved in recent quarters but remains uneven.
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| YOY Sales Growth % | 7.49% | -1.84% | 33.79% | 13.83% | 8.71% | 33.81% | -4.46% | 1.77% | 5.84% | -27.59% | 34.51% | 4.80% | 9.41% |
| OPM % | 4% | 16% | 13% | 18% | 8% | 17% | 10% | 6% | 10% | 6% | 19% | 21% | 21% |
Capital Efficiency & Returns
The capital efficiency and returns of Dishman Carbogen Amcis Ltd. are weak. The ROCE % is low.
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 5% | 6% | 4% | 0% | 1% | 1% | 0% | 2% |
Financial Health & Prudence
Dishman Carbogen Amcis Ltd. faces challenges in financial health and prudence. Borrowings have increased over the years, leading to higher interest expenses.
| Metric | Mar 2011 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Borrowings | 868 | 950 | 1,095 | 1,042 | 1,357 | 1,589 | 1,830 | 2,209 | 2,313 | 2,389 |
| Interest | 56 | 49 | 49 | 57 | 62 | 48 | 57 | 86 | 120 | 159 |
Shareholding & Ownership Structure
The shareholding pattern of Dishman Carbogen Amcis Ltd. shows that promoter holding is consistent. FII holding has increased slightly, while DII holding has decreased.
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Promoters + | 61.40% | 61.40% | 63.17% | 59.32% | 59.32% | 59.32% | 59.32% | 59.32% |
| FIIs + | 9.64% | 7.13% | 9.77% | 6.38% | 5.50% | 9.34% | 8.70% | 9.49% |
| DIIs + | 12.84% | 13.57% | 13.63% | 8.94% | 6.91% | 2.55% | 2.36% | 1.26% |
Weak RiskDishman Carbogen Amcis Ltd. exhibits a high-risk profile. The company's negative ROCE, coupled with increasing debt, signal potential financial instability. High cash conversion cycle indicates inefficiency in working capital management. Declining DII interest adds to the risk.
Foreign exchange or interest rate exposureAverageContingent liability evaluationAverageForeign exchange or interest rate exposure
The company is exposed to interest rate risk due to its increasing borrowings. The interest expenses have been rising.
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest | 16 | 19 | 20 | 22 | 24 | 28 | 27 | 33 | 31 | 32 | 37 | 49 | 42 |
Contingent liability evaluation
Advance from Customers are fluctuating, indicating potential shifts in customer commitments and project pipelines.
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Advance from Customers | 146 | 191 | 156 | 200 | 223 | 295 | 430 | 216 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10170.37Bullish
- SMA 20170.07Bullish
- SMA 50175.78Bearish
- EMA 10170.52Bullish
- EMA 20171.36Bullish
- EMA 50175.57Bearish
- DEMA 10170.29Bullish
- DEMA 20169.02Bullish
- DEMA 50168.93Bullish
- TEMA 10170.93Bullish
- TEMA 20169.82Bullish
- TEMA 50167.75Bullish
- MACD-1.56Bullish
- ADX11.88Weak Trend
- IndicatorValueSignal
- RSI48.14Neutral
- CCI92.54Neutral
- ROC 90.96Bullish
- ROC 142.09Bullish
- ROC 25-1.49Bearish
- Stoch K49.63Neutral
- Stoch D40.69Neutral
- IndicatorValueSignal
- BB Upper172.52Neutral
- BB Middle170.07Neutral
- BB Lower167.62Neutral
- ATR2.15Low Volatility
- IndicatorValueSignal
- MFI56.44Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10170.03Bullish
- SMA 20173.62Bearish
- SMA 50181.10Bearish
- EMA 10171.05Bullish
- EMA 20173.34Bearish
- EMA 50179.59Bearish
- DEMA 10169.48Bullish
- DEMA 20168.62Bullish
- DEMA 50172.21Bearish
- TEMA 10170.43Bullish
- TEMA 20168.66Bullish
- TEMA 50167.26Bullish
- MACD-3.37Bullish
- ADX15.54Weak Trend
- IndicatorValueSignal
- RSI43.31Neutral
- CCI-37.87Neutral
- ROC 92.29Bullish
- ROC 14-1.00Bearish
- ROC 25-2.65Bearish
- Stoch K26.00Neutral
- Stoch D20.64Neutral
- IndicatorValueSignal
- BB Upper184.39Neutral
- BB Middle173.62Neutral
- BB Lower162.84Neutral
- ATR3.13Low Volatility
- IndicatorValueSignal
- MFI29.82Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10173.21Bearish
- SMA 20177.97Bearish
- SMA 50189.41Bearish
- EMA 10173.00Bearish
- EMA 20177.51Bearish
- EMA 50182.61Bearish
- DEMA 10168.60Bullish
- DEMA 20170.21Bullish
- DEMA 50182.24Bearish
- TEMA 10168.71Bullish
- TEMA 20167.25Bullish
- TEMA 50N/AN/A
- MACD-5.54Bearish
- ADX15.04Weak Trend
- IndicatorValueSignal
- RSI39.90Neutral
- CCI-89.54Neutral
- ROC 9-7.19Bearish
- ROC 14-4.98Bearish
- ROC 25-11.05Bearish
- Stoch K11.90Oversold
- Stoch D10.15Oversold
- IndicatorValueSignal
- BB Upper191.25Neutral
- BB Middle177.97Neutral
- BB Lower164.69Neutral
- ATR5.43Low Volatility
- IndicatorValueSignal
- MFI34.31Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
- IndicatorValueSignal
- SMA 10177.99Bearish
- SMA 20186.98Bearish
- SMA 50182.10Bearish
- SMA 100181.57Bearish
- SMA 200222.05Bearish
- EMA 10177.54Bearish
- EMA 20182.11Bearish
- EMA 50183.31Bearish
- EMA 100190.76Bearish
- EMA 200206.24Bearish
- DEMA 10170.67Bullish
- DEMA 20178.14Bearish
- DEMA 50180.56Bearish
- DEMA 100171.68Bearish
- DEMA 200185.74Bearish
- TEMA 10167.98Bullish
- TEMA 20171.64Bearish
- TEMA 50187.11Bearish
- TEMA 100172.49Bearish
- TEMA 200165.97Bullish
- MACD-3.92Bearish
- ADX16.21Weak Trend
- IndicatorValueSignal
- RSI39.90Neutral
- CCI-127.40Oversold
- ROC 14-12.73Bearish
- ROC 25-3.89Bearish
- Stoch K6.85Oversold
- Stoch D7.83Oversold
- IndicatorValueSignal
- BB Upper207.71Neutral
- BB Middle186.98Neutral
- BB Lower166.26Neutral
- ATR8.94Low Volatility
- IndicatorValueSignal
- MFI14.17Oversold
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 20178.62Bullish
- SMA 50226.43Bearish
- EMA 20189.82Bearish
- EMA 50208.59Bearish
- DEMA 20174.20Bullish
- DEMA 50192.80Bearish
- TEMA 20178.05Bullish
- TEMA 50171.88Bullish
- MACD-9.79Bullish
- ADX15.31Weak Trend
- IndicatorValueSignal
- RSI44.40Neutral
- CCI-76.39Neutral
- ROC 1412.43Bullish
- ROC 25-24.00Bearish
- Stoch K63.86Neutral
- Stoch D67.54Neutral
- IndicatorValueSignal
- BB Upper216.69Neutral
- BB Middle178.62Neutral
- BB Lower140.54Neutral
- ATR21.92Low Volatility
- IndicatorValueSignal
- MFI73.68Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 6191.50Bullish
- SMA 12227.11Bearish
- SMA 24221.20Bearish
- EMA 6193.86Bullish
- EMA 12208.62Bearish
- EMA 24210.87Bearish
- DEMA 6175.67Bullish
- DEMA 12194.31Bullish
- DEMA 24219.76Bearish
- TEMA 6173.01Bullish
- TEMA 12175.33Bullish
- TEMA 24209.90Bearish
- MACD10.00Bearish
- ADX17.31Weak Trend
- IndicatorValueSignal
- RSI49.15Neutral
- CCI21.03Neutral
- ROC 25-16.13Bearish
- ROC 505.39Bullish
- Stoch K52.11Neutral
- Stoch D59.37Neutral
- IndicatorValueSignal
- BB Upper306.99Neutral
- BB Middle227.20Neutral
- BB Lower147.40Neutral
- ATR55.75Low Volatility
- IndicatorValueSignal
- MFI66.06Neutral